TY  - JOUR
AU  - Mikus, Maria
AU  - Drobin, Kimi
AU  - Gry, Marcus
AU  - Bachmann, Julie
AU  - Lindberg, Johan
AU  - Yimer, Getnet
AU  - Aklillu, Eleni
AU  - Makonnen, Eyasu
AU  - Aderaye, Getachew
AU  - Roach, James
AU  - Fier, Ian
AU  - Kampf, Caroline
AU  - Göpfert, Jens
AU  - Perazzo, Hugo
AU  - Poynard, Thierry
AU  - Stephens, Camilla
AU  - Andrade, Raúl J
AU  - Lucena, M Isabel
AU  - Arber, Nadir
AU  - Uhlén, Mathias
AU  - Watkins, Paul B
AU  - Schwenk, Jochen M
AU  - Nilsson, Peter
AU  - Schuppe-Koistinen, Ina
PY  - 2016
DO  - 10.1111/liv.13174
UR  - http://hdl.handle.net/10668/10122
T2  - Liver international : official journal of the International Association for the Study of the Liver
AB  - The occurrence of drug-induced liver injury (DILI) is a major issue in all phases of drug development. To identify novel biomarker candidates associated with DILI, we utilised an affinity proteomics strategy, where antibody suspension bead arrays were...
LA  - en
KW  - affinity proteomics
KW  - biomarker discovery
KW  - drug-induced liver injury
KW  - plasma profiling
KW  - suspension bead arrays
KW  - Acetaminophen
KW  - Adult
KW  - Alanine Transaminase
KW  - Antigens, CD
KW  - Biomarkers
KW  - Cadherins
KW  - Chemical and Drug Induced Liver Injury
KW  - Fatty Acid-Binding Proteins
KW  - Female
KW  - HIV Infections
KW  - Heparin
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Proteomics
KW  - Risk Factors
KW  - Tuberculosis
KW  - Young Adult
TI  - Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.
TY  - research article
VL  - 37
ER  -